Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 2,417 | 1,004 | 1,886 | 929 | 0 |
| Cost of Goods | 102 | 158 | 83 | 51 | N/A |
| Gross Profit | 2,315 | 846 | 1,803 | 878 | N/A |
| Operating Expenses | 33,195 | 22,493 | 19,257 | 14,776 | 18,040 |
| Operating Income | -30,778 | -21,489 | -17,371 | -13,847 | -17,538 |
| Interest Expense | 2,865 | 2,514 | 534 | 75 | 94 |
| Other Income | 2,156 | 2,663 | 2,039 | 2,342 | 2,584 |
| Pre-tax Income | -31,487 | -21,340 | -15,866 | -11,580 | -15,048 |
| Net Income Continuous | -31,487 | -21,340 | -15,866 | -11,580 | -15,048 |
| Net Income | $-31,487 | $-21,340 | $-15,866 | $-11,580 | $-15,048 |
| EPS Basic Total Ops | -11,397.72 | -7,678.46 | -5,638.87 | -4,199.16 | -5,398.92 |
| EPS Basic Continuous Ops | -11,107.02 | -7,593.46 | -5,648.65 | -4,125.92 | -5,358.25 |
| EPS Diluted Total Ops | -11,397.72 | -7,678.46 | -5,638.87 | -4,199.16 | -5,398.92 |
| EPS Diluted Continuous Ops | -11,107.02 | -7,593.46 | -5,648.65 | -4,125.92 | -5,358.25 |
| EBITDA(a) | $-26,708 | $-18,246 | $-14,614 | $-11,680 | $-15,821 |